Surgery remains the primary treatment for patients with solid tumours, yet postoperative locoregional recurrence and distant metastasis occur frequently and confer high risks of morbidity and mortality
Deleterious effects of surgery include the initiation of local and/or systemic inflammation, increased catecholamine levels, immunosuppression, a prothrombotic state, and exposure to anaesthetic agents; these processes overlap with cancer-promoting signalling pathways
Cancer cells that escape resection are subject to perioperative physiological changes and might disseminate and colonize distant organs, thus contributing to postoperative cancer recurrence
Perioperative use of β-adrenoceptor antagonists, anti-inflammatory drugs, intravenous anaesthetics, and antithrombotic agents is linked with improved survival outcomes in patients with cancer
>60% of patients with cancer are treated with surgery; therefore, offsetting the deleterious effects of surgery by use of affordable and readily available therapies might rapidly improve the postoperative survival of patients with cancer
Surgery is a mainstay treatment for patients with solid tumours. However, despite surgical resection with a curative intent and numerous advances in the effectiveness of (neo)adjuvant therapies, metastatic disease remains common and carries a high risk of mortality. The biological perturbations that accompany the surgical stress response and the pharmacological effects of anaesthetic drugs, paradoxically, might also promote disease recurrence or the progression of metastatic disease. When cancer cells persist after surgery, either locally or at undiagnosed distant sites, neuroendocrine, immune, and metabolic pathways activated in response to surgery and/or anaesthesia might promote their survival and proliferation. A consequence of this effect is that minimal residual disease might then escape equilibrium and progress to metastatic disease. Herein, we discuss the most promising proposals for the refinement of perioperative care that might address these challenges. We outline the rationale and early evidence for the adaptation of anaesthetic techniques and the strategic use of anti-adrenergic, anti-inflammatory, and/or antithrombotic therapies. Many of these strategies are currently under evaluation in large-cohort trials and hold promise as affordable, readily available interventions that will improve the postoperative recurrence-free survival of patients with cancer.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Mehlen, P. & Puisieux, A. Metastasis: a question of life or death. Nat. Rev. Cancer 6, 449–458 (2006).
Murthy, B. L. et al. Postoperative wound complications and systemic recurrence in breast cancer. Br. J. Cancer 97, 1211–1217 (2007).
Beecher, S. M., O'Leary, D. P., McLaughlin, R., Sweeney, K. J. & Kerin, M. J. Influence of complications following immediate breast reconstruction on breast cancer recurrence rates. Br. J. Surg. 103, 391–398 (2016).
Lu, Z. R., Rajendran, N., Lynch, A. C., Heriot, A. G. & Warrier, S. K. Anastomotic leaks after restorative resections for rectal cancer compromise cancer outcomes and survival. Dis. Colon Rectum 59, 236–244 (2016).
Paget, S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 8, 98–101 (1989).
Brown, D. C., Purushotham, A. D., Birnie, G. D. & George, W. D. Detection of intraoperative tumor cell dissemination in patients with breast cancer by use of reverse transcription and polymerase chain reaction. Surgery 117, 95–101 (1995).
Hashimoto, M. et al. Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer. Interact. Cardiovasc. Thorac. Surg. 18, 775–783 (2014).
Peach, G., Kim, C., Zacharakis, E., Purkayastha, S. & Ziprin, P. Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review. Br. J. Cancer 102, 1327–1334 (2010).
Hiratsuka, S., Watanabe, A., Aburatani, H. & Maru, Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369–1375 (2006).
Sceneay, J. et al. Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res. 72, 3906–3911 (2012).
Kurosawa, S. & Kato, M. Anesthetics, immune cells, and immune responses. J. Anesth. 22, 263–277 (2008).
Zhou, L. et al. Propranolol attenuates surgical stress-induced elevation of the regulatory T cell response in patients undergoing radical mastectomy. J. Immunol. 196, 3460–3469 (2016).
Demicheli, R., Retsky, M. W., Hrushesky, W. J. M. & Baum, M. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures. Nat. Clin. Pract. Oncol. 4, 699–710 (2007).
Retsky, M. et al. Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review. Curr. Med. Chem. 20, 4163–4176 (2013).
Lee, J.-W. et al. Surgical stress promotes tumor growth in ovarian carcinoma. Clin. Cancer Res. 15, 2695–2702 (2009).
Kelsey, C. R. et al. Metastasis dynamics for non-small-cell lung cancer: effect of patient and tumor-related factors. Clin. Lung Cancer 14, 425–432 (2013).
Oosterling, S. J., van der Bij, G. J., van Egmond, M. & van der Sijp, J. R. M. Surgical trauma and peritoneal recurrence of colorectal carcinoma. Eur. J. Surg. Oncol. 31, 29–37 (2005).
Dillekås, H. et al. The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases. Breast Cancer Res. Treat. 158, 169–178 (2016).
Isern, A. E. et al. Risk of recurrence following delayed large flap reconstruction after mastectomy for breast cancer. Br. J. Surg. 98, 659–666 (2011).
Mirnezami, A. et al. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann. Surg. 253, 890–899 (2011).
Wigmore, T. J., Mohammed, K. & Jhanji, S. Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery: a retrospective analysis. Anesthesiology 124, 69–79 (2016).
Enlund, M. et al. The choice of anaesthetic — sevoflurane or propofol — and outcome from cancer surgery: a retrospective analysis. Ups. J. Med. Sci. 119, 251–261 (2014).
Alkire, B. C. et al. Global access to surgical care: a modelling study. Lancet Glob. Health 3, e316–e323 (2015).
Sullivan, R. et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 12, 933–980 (2011).
Lambert, A. W., Pattabiraman, D. R. & Weinberg, R. A. Emerging biological principles of metastasis. Cell 168, 670–691 (2017).
Klein, C. A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 9, 302–312 (2009).
Schmidt-Kittler, O. et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc. Natl Acad. Sci. USA 100, 7737–7742 (2003).
Rhim, A. D. et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349–361 (2012).
Hosseini, H. et al. Early dissemination seeds metastasis in breast cancer. Nature 540, 552–558 (2016).
Nagrath, S. et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235–1239 (2007).
Rahbari, N. N. et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 138, 1714–1726 (2010).
Hardingham, J. E. et al. Detection and clinical significance of circulating tumor cells in colorectal cancer — 20 years of progress. Mol. Med. 21 (Suppl. 1), S25–S31 (2015).
Martin, O. A., Anderson, R. L., Narayan, K. & MacManus, M. P. Does the mobilization of circulating tumour cells during cancer therapy cause metastasis? Nat. Rev. Clin. Oncol. 14, 32–44 (2017).
Hayashi, K. et al. Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res. 67, 8223–8228 (2007).
Tvedskov, T. F., Jensen, M.-B., Kroman, N. & Balslev, E. Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancer. Breast Cancer Res. Treat. 131, 223–229 (2012).
Greco, K. V., Lara, P. F., Oliveira-Filho, R. M., Greco, R. V. & Sudo-Hayashi, L. S. Lymphatic regeneration across an incisional wound: inhibition by dexamethasone and aspirin, and acceleration by a micronized purified flavonoid fraction. Eur. J. Pharmacol. 551, 131–142 (2006).
Swartz, M. A. & Lund, A. W. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat. Rev. Cancer 12, 210–219 (2012).
Hirakawa, S. et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 201, 1089–1099 (2005).
Cao, R. et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6, 333–345 (2004).
Carpinteri, S. et al. Peritoneal tumorigenesis and inflammation are ameliorated by humidified-warm carbon dioxide insufflation in the mouse. Ann. Surg. Oncol. 22 (Suppl. 3), S1540–S1547 (2015).
Schott, A. et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann. Surg. 227, 372–379 (1998).
Green, B. L. et al. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br. J. Surg. 100, 75–82 (2013).
Kadar, N. Port-site recurrences following laparoscopic operations for gynaecological malignancies. Br. J. Obstet. Gynaecol. 104, 1308–1313 (1997).
Song, J. et al. Port site metastasis after surgery for renal cell carcinoma: harbinger of future metastasis. J. Urol. 192, 364–368 (2014).
Downey, R. J., McCormack, P. & LoCicero, J. Dissemination of malignant tumors after video-assisted thoracic surgery: a report of twenty-one cases. The Video-Assisted Thoracic Surgery Study Group. J. Thorac. Cardiovasc. Surg. 111, 954–960 (1996).
Berger-Richardson, D. et al. Trends in port-site metastasis after laparoscopic resection of incidental gallbladder cancer: a systematic review. Surgery 161, 618–627 (2017).
Chang, H. Y. et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc. Natl Acad. Sci. USA 102, 3738–3743 (2005).
Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650–1659 (1986).
Murdoch, C., Muthana, M., Coffelt, S. B. & Lewis, C. E. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 8, 618–631 (2008).
Elinav, E. et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 13, 759–771 (2013).
Zhao, H., Feng, Y., Wang, Y., Yang, B. & Xing, Z. Comparison of different loading dose of celecoxib on postoperative anti-inflammation and analgesia in patients undergoing endoscopic nasal surgery-200 mg is equivalent to 400 mg. Pain Med. 12, 1267–1275 (2011).
Wang, D. & DuBois, R. N. Eicosanoids and cancer. Nat. Rev. Cancer 10, 181–193 (2010).
Ruan, D. & So, S.-P. Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo. Life Sci. 116, 43–50 (2014).
Chang, N., Goodson, W. H., Gottrup, F. & Hunt, T. K. Direct measurement of wound and tissue oxygen tension in postoperative patients. Ann. Surg. 197, 470–478 (1983).
Hong, W. X. et al. The role of hypoxia-inducible factor in wound healing. Adv. Wound Care 3, 390–399 (2014).
Nakazawa, M. S., Keith, B. & Simon, M. C. Oxygen availability and metabolic adaptations. Nat. Rev. Cancer 16, 663–673 (2016).
Hayashi, T. et al. Impact of infectious complications on gastric cancer recurrence. Gastr. Cancer 18, 368–374 (2015).
Murthy, S. M. et al. The influence of surgical trauma on experimental metastasis. Cancer 64, 2035–2044 (1989).
Stanczyk, M., Olszewski, W. L., Gewartowska, M. & Maruszynski, M. Cancer seeding contributes to intestinal anastomotic dehiscence. World J. Surg. Oncol. 11, 302 (2013).
Abramovitch, R., Marikovsky, M., Meir, G. & Neeman, M. Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI. Br. J. Cancer 77, 440–447 (1998).
Abramovitch, R., Marikovsky, M., Meir, G. & Neeman, M. Stimulation of tumour growth by wound-derived growth factors. Br. J. Cancer 79, 1392–1398 (1999).
Antonio, N. et al. The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J. 34, 2219–2236 (2015).
Tsuchiya, Y. et al. Increased surgical stress promotes tumor metastasis. Surgery 133, 547–555 (2003).
Choi, J. E. et al. Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study. Cancer Med. 4, 825–833 (2015).
McSorley, S. T., Watt, D. G., Horgan, P. G. & McMillan, D. C. Postoperative systemic inflammatory response, complication severity, and survival following surgery for colorectal cancer. Ann. Surg. Oncol. 23, 2832–2840 (2016).
Desborough, J. P. The stress response to trauma and surgery. Br. J. Anaesth. 85, 109–117 (2000).
Sloan, E. K. et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 70, 7042–7052 (2010).
Le, C. P. et al. Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination. Nat. Commun. 7, 10634 (2016).
Kim-Fuchs, C. et al. Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment. Brain Behav. Immun. 40, 40–47 (2014).
Thaker, P. H. et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12, 939–944 (2006).
Masur, K., Niggemann, B., Zanker, K. S. & Entschladen, F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by β-blockers. Cancer Res. 61, 2866–2869 (2001).
Wolter, J. K. et al. Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma. Oncotarget 5, 161–172 (2014).
Magnon, C. et al. Autonomic nerve development contributes to prostate cancer progression. Science 341, 1236361 (2013).
Hassan, S. et al. Behavioral stress accelerates prostate cancer development in mice. J. Clin. Invest. 123, 874–886 (2013).
Moretti, S. et al. β-Adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines. Lab. Invest. 93, 279–290 (2013).
Chang, A. et al. β2-Adrenoceptors on tumor cells play a critical role in stress-enhanced metastasis in a mouse model of breast cancer. Brain Behav. Immun. 57, 106–115 (2016).
Pon, C. K., Lane, J. R., Sloan, E. K. & Halls, M. L. The β2-adrenoceptor activates a positive cAMP-calcium feedforward loop to drive breast cancer cell invasion. FASEB J. 30, 1144–1154 (2016).
Creed, S. J. et al. β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion. Breast Cancer Res. 17, 145 (2015).
Kim, T.-H. et al. Cancer cells become less deformable and more invasive with activation of β-adrenergic signaling. J. Cell. Sci. 129, 4563–4575 (2016).
McGeown, J. G. Splanchnic nerve stimulation increases the lymphocyte output in mesenteric efferent lymph. Pflugers Arch. 422, 558–563 (1993).
Hiller, J. G. et al. Neuraxial anesthesia reduces lymphatic flow: proof-of-concept in first in-human study. Anesth. Analg. 123, 1325–1327 (2016).
Koltun, W. A. et al. Awake epidural anesthesia is associated with improved natural killer cell cytotoxicity and a reduced stress response. Am. J. Surg. 171, 68–72 (1996).
Elefteriou, F. et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434, 514–520 (2005).
Campbell, J. P. et al. Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol. 10, e1001363 (2012).
Chiang, S. P. H., Cabrera, R. M. & Segall, J. E. Tumor cell intravasation. Am. J. Physiol., Cell Physiol. 311, C1–C14 (2016).
Lee, S. W., Whelan, R. L., Southall, J. C. & Bessler, M. Abdominal wound tumor recurrence after open and laparoscopic-assisted splenectomy in a murine model. Dis. Colon Rectum 41, 824–831 (1998).
Stone, R. L. et al. Paraneoplastic thrombocytosis in ovarian cancer. N. Engl. J. Med. 366, 610–618 (2012).
Paramanathan, A., Saxena, A. & Morris, D. L. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg. Oncol. 23, 31–39 (2014).
Konstantopoulos, K. & McIntire, L. V. Effects of fluid dynamic forces on vascular cell adhesion. J. Clin. Invest. 98, 2661–2665 (1996).
Im, J. H. et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res. 64, 8613–8619 (2004).
Benish, M. et al. The marginating-pulmonary immune compartment in mice exhibits increased NK cytotoxicity and unique cellular characteristics. Immunol. Res. 58, 28–39 (2014).
Gil-Bernabé, A. M. et al. Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood 119, 3164–3175 (2012).
Hu, L., Lee, M., Campbell, W., Perez-Soler, R. & Karpatkin, S. Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis. Blood 104, 2746–2751 (2004).
Terraube, V., Marx, I. & Denis, C. V. Role of von Willebrand factor in tumor metastasis. Thromb. Res. 120 (Suppl. 2), S64–S70 (2007).
Cools-Lartigue, J. et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J. Clin. Invest. 123, 3446–3458 (2013).
Tohme, S. et al. Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress. Cancer Res. 76, 1367–1380 (2016).
Vlodavsky, I. et al. Heparanase, heparin and the coagulation system in cancer progression. Thromb. Res. 120 (Suppl. 2), S112–S120 (2007).
Nadir, Y. et al. Heparanase induces tissue factor expression in vascular endothelial and cancer cells. J. Thromb. Haemost. 4, 2443–2451 (2006).
Kaplan, R. N., Psaila, B. & Lyden, D. Bone marrow cells in the 'pre-metastatic niche': within bone and beyond. Cancer Metastasis Rev. 25, 521–529 (2006).
Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559–563 (2014).
Pietra, G. et al. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res. 72, 1407–1415 (2012).
Eddy, J. L., Krukowski, K., Janusek, L. & Mathews, H. L. Glucocorticoids regulate natural killer cell function epigenetically. Cell. Immunol. 290, 120–130 (2014).
Glasner, A. et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a β-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J. Immunol. 184, 2449–2457 (2010).
Benish, M. et al. Perioperative use of β-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann. Surg. Oncol. 15, 2042–2052 (2008).
Yakar, I. et al. Prostaglandin E2 suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann. Surg. Oncol. 10, 469–479 (2003).
Cata, J. P., Conrad, C. & Rezvani, K. Potential use of natural killer cell transfer therapy in the perioperative period to improve oncologic outcomes. Scientifica 2015, 732438 (2015).
Buggy, D. J. et al. Consensus statement from the BJA Workshop on Cancer and Anaesthesia. Br. J. Anaesth. 114, 2–3 (2015).
Barron, T. I., Connolly, R. M., Sharp, L., Bennett, K. & Visvanathan, K. Beta blockers and breast cancer mortality: a population- based study. J. Clin. Oncol. 29, 2635–2644 (2011).
Hiller, J. G., Hacking, M. B., Link, E. K., Wessels, K. L. & Riedel, B. J. Perioperative epidural analgesia reduces cancer recurrence after gastro-oesophageal surgery. Acta Anaesthesiol. Scand. 58, 281–290 (2014).
De Giorgi, V. et al. β-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-up. Melanoma Res. 27, 268–270 (2017).
Léauté-Labrèze, C. et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N. Engl. J. Med. 372, 735–746 (2015).
Chow, W. et al. Growth attenuation of cutaneous angiosarcoma with propranolol-mediated β-blockade. JAMA Dermatol. 151, 1226–1229 (2015).
Childers, W. K., Hollenbeak, C. S. & Cheriyath, P. β-blockers reduce breast cancer recurrence and breast cancer death: a meta-analysis. Clin. Breast Cancer 15, 426–431 (2015).
Zhang, J. et al. Norepinephrine induced epithelial-mesenchymal transition in HT-29 and A549 cells in vitro. J. Cancer Res. Clin. Oncol. 142, 423–435 (2016).
Shaashua, L. et al. Perioperative COX-2 and β-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a phase-II randomized trial. Clin. Cancer Res. 23, 4651–4661 (2017).
POISE Study Group et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371, 1839–1847 (2008).
Khadke, V. V., Khadke, S. V. & Khare, A. Oral propranolol — efficacy and comparison of two doses for peri-operative anxiolysis. J. Indian Med. Assoc. 110, 457–460 (2012).
Day, A. R., Smith, R. V. P., Scott, M. J. P., Fawcett, W. J. & Rockall, T. A. Randomized clinical trial investigating the stress response from two different methods of analgesia after laparoscopic colorectal surgery. Br. J. Surg. 102, 1473–1479 (2015).
Gu, C.-Y., Zhang, J., Qian, Y.-N. & Tang, Q.-F. Effects of epidural anesthesia and postoperative epidural analgesia on immune function in esophageal carcinoma patients undergoing thoracic surgery. Mol. Clin. Oncol. 3, 190–196 (2015).
Xu, F. et al. Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis. Oncotarget 8, 6003–6012 (2016).
McGeown, J. G., McHale, N. G. & Thornbury, K. D. The effect of electrical stimulation of the sympathetic chain on peripheral lymph flow in the anaesthetized sheep. J. Physiol. 393, 123–133 (1987).
Horowitz, M., Neeman, E., Sharon, E. & Ben-Eliyahu, S. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat. Rev. Clin. Oncol. 12, 213–226 (2015).
Lennon, F. E. et al. Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis. Anesthesiology 116, 857–867 (2012).
Page, G. G., Blakely, W. P. & Ben-Eliyahu, S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 90, 191–199 (2001).
Weng, M. et al. The effect of neuraxial anesthesia on cancer recurrence and survival after cancer surgery: an updated meta-analysis. Oncotarget 7, 15262–15273 (2016).
Sun, Y., Li, T. & Gan, T. J. The effects of perioperative regional anesthesia and analgesia on cancer recurrence and survival after oncology surgery: a systematic review and meta-analysis. Reg. Anesth. Pain Med. 40, 589–598 (2015).
Karnezis, T. et al. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 21, 181–195 (2012).
Hiller, J. G. et al. Impact of celecoxib on inflammation during cancer surgery: a randomized clinical trial. Can. J. Anaesth. 64, 497–505 (2017).
Zhu, Y., Wang, S., Wu, H. & Wu, Y. Effect of perioperative parecoxib on postoperative pain and local inflammation factors PGE2 and IL-6 for total knee arthroplasty: a randomized, double-blind, placebo-controlled study. Eur. J. Orthop. Surg. Traumatol. 24, 395–401 (2013).
Wang, L.-D. et al. Effects of preemptive analgesia with parecoxib sodium on haemodynamics and plasma stress hormones in surgical patients with thyroid carcinoma. Asian Pac. J. Cancer Prev. 16, 3977–3980 (2015).
Ma, W., Wang, K., Du, J., Luan, J. & Lou, G. Multi-dose parecoxib provides an immunoprotective effect by balancing T helper 1 (Th1), Th2, Th17 and regulatory T cytokines following laparoscopy in patients with cervical cancer. Mol. Med. Rep. 11, 2999–3008 (2015).
Shen, J.-C. et al. Flurbiprofen improves dysfunction of T-lymphocyte subsets and natural killer cells in cancer patients receiving post-operative morphine analgesia. Int. J. Clin. Pharmacol. Ther. 52, 669–675 (2014).
Elmets, C. A. et al. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J. Natl Cancer Inst. 102, 1835–1844 (2010).
Mao, J. T. et al. Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev. Res. 4, 984–993 (2011).
Lönnroth, C. et al. Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer. Cancer Immun. 8, 5 (2008).
Sooriakumaran, P. et al. A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer. Anticancer Res. 29, 1483–1488 (2009).
Forget, P. et al. Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth. Analg. 110, 1630–1635 (2010).
Restivo, A. et al. Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer. Br. J. Cancer 113, 1133–1139 (2015).
Yeh, C.-C. et al. Nonsteroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: a nationwide cohort study. Ann. Surg. 261, 521–526 (2015).
Shapiro, J., Jersky, J., Katzav, S., Feldman, M. & Segal, S. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J. Clin. Invest. 68, 678–685 (1981).
Wu, L., Zhao, H., Wang, T., Pac-Soo, C. & Ma, D. Cellular signaling pathways and molecular mechanisms involving inhalational anesthetics-induced organoprotection. J. Anesth. 28, 740–758 (2014).
Tavare, A. N., Perry, N. J. S., Benzonana, L. L., Takata, M. & Ma, D. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int. J. Cancer 130, 1237–1250 (2012).
Iwasaki, M. et al. Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. Oncotarget 7, 26042–26056 (2016).
Huitink, J. M. et al. Volatile anesthetics modulate gene expression in breast and brain tumor cells. Anesth. Analg. 111, 1411–1415 (2010).
Benzonana, L. L. et al. Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro. Anesthesiology 119, 593–605 (2013).
Huang, H. et al. Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. Br. J. Cancer 111, 1338–1349 (2014).
Luo, X. et al. Impact of isoflurane on malignant capability of ovarian cancer in vitro. Br. J. Anaesth. 114, 831–839 (2015).
Elena, G. et al. Effects of repetitive sevoflurane anaesthesia on immune response, select biochemical parameters and organ histology in mice. Lab. Anim. 37, 193–203 (2003).
Desmond, F., McCormack, J., Mulligan, N., Stokes, M. & Buggy, D. J. Effect of anaesthetic technique on immune cell infiltration in breast cancer: a follow-up pilot analysis of a prospective, randomised, investigator-masked study. Anticancer Res. 35, 1311–1319 (2015).
Zhu, M. et al. Isoflurane enhances the malignant potential of glioblastoma stem cells by promoting their viability, mobility in vitro and migratory capacity in vivo. Br. J. Anaesth. 116, 870–877 (2016).
Pandit, J. J. et al. 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors. Br. J. Anaesth. 113, 549–559 (2014).
Chen, R.-M. et al. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. Ann. NY Acad. Sci. 1042, 262–271 (2005).
Lee, C.-J., Tai, Y.-T., Lin, Y.-L. & Chen, R.-M. Molecular mechanisms of propofol-involved suppression of no biosynthesis and inducible iNOS gene expression in LPS-stimulated macrophage-like raw 264.7 cells. Shock 33, 93–100 (2010).
Inada, T., Hirota, K. & Shingu, K. Intravenous anesthetic propofol suppresses prostaglandin E2 and cysteinyl leukotriene production and reduces edema formation in arachidonic acid-induced ear inflammation. J. Immunotoxicol. 12, 261–265 (2015).
Markovic-Bozic, J. et al. Effect of propofol and sevoflurane on the inflammatory response of patients undergoing craniotomy. BMC Anesthesiol. 16, 18 (2016).
Inada, T. et al. Effect of propofol and isoflurane anaesthesia on the immune response to surgery. Anaesthesia 59, 954–959 (2004).
Melamed, R., Bar-Yosef, S., Shakhar, G., Shakhar, K. & Ben-Eliyahu, S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth. Analg. 97, 1331–1339 (2003).
Wu, K.-C. et al. Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. Anticancer Res. 32, 4833–4842 (2012).
Mammoto, T. et al. Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett. 184, 165–170 (2002).
Kushida, A., Inada, T. & Shingu, K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol. Immunotoxicol. 29, 477–486 (2007).
Lee, J. H., Kang, S. H., Kim, Y., Kim, H. A. & Kim, B. S. Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Kor. J. Anesthesiol. 69, 126–132 (2016).
Mikami, J. et al. Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study. Gastr. Cancer 19, 817–826 (2016).
Palumbo, J. S. et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105, 178–185 (2005).
Stegeman, I., Bossuyt, P. M., Yu, T., Boyd, C. & Puhan, M. A. Aspirin for primary prevention of cardiovascular disease and cancer. A benefit and harm analysis. PLoS ONE 10, e0127194 (2015).
Lou, X.-L. et al. Interaction between circulating cancer cells and platelets: clinical implication. Chin. J. Cancer Res. 27, 450–460 (2015).
Algra, A. M. & Rothwell, P. M. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 13, 518–527 (2012).
Liu, J.-F., Jamieson, G. G., Wu, T.-C., Zhu, G.-J. & Drew, P. A. A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia. Ann. Surg. Oncol. 16, 1397–1402 (2009).
Devereaux, P. J. et al. Aspirin in patients undergoing noncardiac surgery. N. Engl. J. Med. 370, 1494–1503 (2014).
Elwood, P. C. et al. Aspirin in the treatment of cancer: reductions in metastatic spread and in mortality: a systematic review and meta-analyses of published studies. PLoS ONE 11, e0152402 (2016).
Tieken, C. & Versteeg, H. H. Anticoagulants versus cancer. Thromb. Res. 140 (Suppl. 1), S148–S153 (2016).
Niers, T. M. H. et al. Mechanisms of heparin induced anti-cancer activity in experimental cancer models. Crit. Rev. Oncol. Hematol. 61, 195–207 (2007).
Taromi, S. et al. PO-33 - Heparin suppresses progression of small cell lung cancer (SCLC) in an orthotopic mouse model. Thromb. Res. 140 (Suppl. 1), S188 (2016).
Mousa, S. A. & Petersen, L. J. Anti-cancer properties of low-molecular-weight heparin: preclinical evidence. Thromb. Haemost. 102, 258–267 (2009).
Van Sluis, G. L. et al. A low molecular weight heparin inhibits experimental metastasis in mice independently of the endothelial glycocalyx. PLoS ONE 5, e11200 (2010).
Bonten, T. N. et al. Effect of β-blockers on platelet aggregation: a systematic review and meta-analysis. Br. J. Clin. Pharmacol. 78, 940–949 (2014).
McSorley, S. T., Horgan, P. G. & McMillan, D. C. The impact of the type and severity of postoperative complications on long-term outcomes following surgery for colorectal cancer: a systematic review and meta-analysis. Crit. Rev. Oncol. Hematol. 97, 168–177 (2016).
Davis, C. et al. Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009–2013. BMJ 359, j4530 (2017).
The work of the authors is supported by the Australian and New Zealand College of Anaesthetists, The David and Lorelle Skewes Foundation, the Peter Mac Foundation, and the National Cancer Institute (CA160890). N.J.P is the recipient of a Cancer Research UK Clinical Research Fellowship. Work in the G.P lab is supported by the British Journal of Anaesthesia/Royal College of Anaesthetists via the National Institute of Academic Anaesthesia, Cancer Research UK Grand Challenge award (C59824/A25044), and the Institute of Cancer Research.
The authors declare no competing financial interests.
About this article
Cite this article
Hiller, J., Perry, N., Poulogiannis, G. et al. Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol 15, 205–218 (2018). https://doi.org/10.1038/nrclinonc.2017.194
Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study
Clinical and Translational Medicine (2020)
Local and Regional Anesthesia (2020)
Interpreting Breast Cancer Survival Data by the Hazard Function: Remarkable Findings from Event Dynamics